Active	Status	Sponsor type	Region	Phase	Filter
1 Active 2 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
rozibafusp alfa (AMG 570) / AstraZeneca, Amgen
NCT04058028 / 2019-000328-16: Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE) Jan 2021 - Dec 2021 : From trial for SLE	Completed	2	244	Europe, Canada, Japan, US, RoW	Rozibafusp Alfa, Placebo for Rozibafusp Alfa	Amgen	Systemic Lupus Erythematosus (SLE)	07/23	07/23